Laboratory Results Summary
|
|
|
- Crystal Williams
- 5 years ago
- Views:
Transcription
1 Laboratory Results Summary Laboratory CO1033AI Test event 2 of 3 CAP LAP Number Page Print Date 9 / /Jul/04 Program Syphilis (SYPH435) Results Deadline 2008/Jun/24 Subscription ID Analyte Result Reason Grade Actual Score Code Results Count Statistical Count Results Answer % PG: Method/Submethod Instrument Reagent» Syphilis qualitative % A Reactive ACC 27 1 Reactive 100% ID: Immunoassay/Enzymatic Manual determination Organon Teknika SpiroTek Weak Reactive 0% Reagin II B Reactive ACC 27 1 Reactive 100% ID: Immunoassay/Enzymatic Manual determination Organon Teknika SpiroTek Weak Reactive 0% Reagin II C Non Reactive ACC 27 1 Non Reactive 100% ID: Immunoassay/Enzymatic Manual determination Organon Teknika SpiroTek Reagin II D Non Reactive ACC 27 1 Non Reactive 100% ID: Immunoassay/Enzymatic Manual determination Organon Teknika SpiroTek Reagin II E Reactive ACC 27 1 Reactive 100% ID: Immunoassay/Enzymatic Manual determination Organon Teknika SpiroTek Weak Reactive 0% Reagin II Grade: ACC - ; UNACC - Unacceptable; *ACC or *UNACC (i.e. grade preceded by an asterisk) indicates ungradable due to lack of (80%) peer group concensus or insufficient peer group.» This result is designated for regulatory purposes. Peer Group(PG) Codes: AR-all results; ME-method; SM-submethod; RM-reagent manufacturer; RG-reagent group; RE-reagent; IM-instrument manufacturer; IG-instrument group; ID-instrument model Reason Codes: 1(Failure to participate (0% score)); 11(below linear/detection limit); 2(Failure - Excl Requested (100% score)); 22(above linear/detection limit); 88(testing suspended during test event);
2 EVALUATION DAT-A 2008 Direct Antiglobulin Test INSTITUTION: ATTENTION: CAP NUMBER: Kit# 1 KIT INFORMATION: Kit ID: /4/2008 3/17/2008 Next Mailing Date: 10/13/2008 COPIED TO: LAP CAP LEGEND: Exception Reason Codes appearing in this evaluation: [27] = Lack of participant or referee consensus. Reviewed By Date Page 1 of 2
3 DAT-A 2008 Direct Antiglobulin Test Test Method Specimen Your Result Intended Response Your Grade DAT Poly GEL TESTING DAT /4/2008 3/17/2008 DAT-02 DAT-03 NEGATIVE NEGATIVE DAT IgG GEL TESTING DAT-01 NEGATIVE Unacceptable DAT-02 DAT-03 NEGATIVE NEGATIVE DAT C3d GEL TESTING DAT-01 DAT-02 [27] DAT-03 NEGATIVE NEGATIVE Page 2 of 2
4 EVALUATION J-A 2008 Transfusion Medicine (Comp) INSTITUTION: ATTENTION: CAP NUMBER: Kit# 1 KIT INFORMATION: Kit ID: /11/2008 3/24/2008 Next Mailing Date: 6/16/2008 COPIED TO: LAP CAP LEGEND: Exception Reason Codes appearing in this evaluation: [11] = Unable to analyze (documentation to be provided by laboratory). [26] = Educational challenge. Reviewed By Date Page 1 of 8
5 J-A 2008 Transfusion Medicine (Comp) Test Method Specimen Your Result Intended Response Your Grade ABO Group J-01R GROUP A GROUP A GROUP A /11/2008 3/24/2008 J-02R GROUP A GROUP A GROUP A1 J-03R GROUP O GROUP O J-04R GROUP AB GROUP AB GROUP A1B J-05R GROUP O GROUP O Rh Type J-01R RH RH J-02R RH RH J-03R RH RH J-04R RH NEGATIVE RH NEGATIVE J-05R RH RH Page 2 of 8
6 J-A 2008 Transfusion Medicine (Comp) Test Method Specimen Your Result Intended Response Your Grade Antibody Detection J-01S ANTIBODY DETECTED ANTIBODY DETECTED /11/2008 3/24/2008 J-02S ANTIBODY NOT DETECTED ANTIBODY NOT DETECTED J-03S ANTIBODY NOT DETECTED ANTIBODY NOT DETECTED J-04S ANTIBODY DETECTED ANTIBODY DETECTED J-05S ANTIBODY DETECTED ANTIBODY DETECTED Antibody ID J-01S J-02S J-03S J-04S J-05S [11] [11] [11] [11] [11] Crossmatch Serology J-01S J-02S J-03S J-04S J-05S C Type J-06R 4+ [26] Page 3 of 8
7 J-A 2008 Transfusion Medicine (Comp) Test Method Specimen Your Result Intended Response Your Grade E Type J-06R NEGATIVE 0 [26] c Type J-06R 4+ [26] e Type J-06R 4+ [26] /11/2008 3/24/2008 Page 4 of 8
8 J-A 2008 Transfusion Medicine (Comp) /11/2008 3/24/2008 CAP #: Regulated Analyte Test Event Score % Unexpected Antibody Det CAP Subspecialty : Unexpected Antibody Det Test Event Score % Test Event Score % JAT-B 5 / JAT-C J-A Current Event Cumulative CLIA Performance '88 Performance Interpretation Interpretation Satisfactory Unexpected Antibody Det Satisfactory Page 5 of 8
9 J-A 2008 Transfusion Medicine (Comp) /11/2008 3/24/2008 ABO Group Rh (D) Type CAP #: Regulated Analyte Test Event Score % CAP Subspecialty : ABO Group/Rh Type Test Event Score % Test Event Score % JAT-B 5 / JAT-C J-A JAT-B 5 / JAT-C J-A Current Event Cumulative CLIA Performance '88 Performance Interpretation Interpretation Satisfactory Satisfactory ABO Group/Rh Type 10/ / / Satisfactory Page 6 of 8
10 J-A 2008 Transfusion Medicine (Comp) /11/2008 3/24/2008 CAP #: Regulated Analyte Test Event Score % Antibody Identification CAP Subspecialty : Antibody Identification Test Event Score % Test Event Score % J-A Current Event Cumulative CLIA Performance '88 Performance Interpretation Interpretation Satisfactory Antibody Identification Satisfactory Page 7 of 8
11 J-A 2008 Transfusion Medicine (Comp) /11/2008 3/24/2008 CAP #: Regulated Analyte Test Event Score % Compatibility Testing CAP Subspecialty : Compatibility Testing Test Event Score % Test Event Score % J-A Current Event Cumulative CLIA Performance '88 Performance Interpretation Interpretation Satisfactory Compatibility Testing Satisfactory Page 8 of 8
12 EVALUATION VM-B 2008 Viral Markers INSTITUTION: ATTENTION: CAP NUMBER: Kit# 1 KIT INFORMATION: Kit ID: /2008 6/12/2008 Next Mailing Date: 8/22008 COPIED TO: LAP CAP LEGEND: Exception Reason Codes appearing in this evaluation: <NONE> Reviewed By Date Page 1 of 5
13 VM-B 2008 Viral Markers Test Method Specimen Your Result Intended Response Your Grade HBsAg FLUORESCENT EIA VM /2008 6/12/2008 VM1-15 VM1-16 VM1-17 VM1-18 Anti-HBs FLUORESCENT EIA VM1-14 VM1-15 VM1-16 VM1-17 VM1-18 Page 2 of 5
14 VM-B 2008 Viral Markers Test Method Specimen Your Result Intended Response Your Grade Anti-HAV(IgM) FLUORESCENT EIA VM /2008 6/12/2008 VM1-15 VM1-16 VM1-17 VM1-18 Anti-HIV 1/2 RECOMBINANT EIA VM1-14 VM1-15 VM1-16 VM1-17 VM1-18 Page 3 of 5
15 VM-B 2008 Viral Markers Test Method Specimen Your Result Intended Response Your Grade Anti-HCV ABBOTT VM /2008 6/12/2008 VM1-15 VM1-16 VM1-17 VM1-18 Page 4 of 5
16 VM-B 2008 Viral Markers /2008 6/12/2008 CAP #: Regulated Analyte Test Event Score % Alpha-1-Antitrypsin Alpha-Fetoprotein Antinuclear Antibody Antistreptolysin O Anti-HIV Complement C3 Complement C4 Hepatitis (HBsAg) IgA IgG IgE CAP Subspecialty : General Immunology S-C 5 / S-A K-C 5 / K-A S-C 5 / S-A S-C 5 / S-A Test Event Score % Test Event Score % VM-C 5 / VM-A VM-B S-C 4 / 5 80 S-A S-C 5 / S-A VM-C 5 / VM-A VM-B S-C 5 / S-A S-C 5 / S-A S-C 5 / S-A 4/ Current Event Cumulative CLIA Performance '88 Performance Interpretation Interpretation Satisfactory Satisfactory IgM S-C 3 / 5 60 S-A <1> Rheumatoid Factor S-C 5 / S-A General Immunology 62/ / / Satisfactory <1> Currently successful - At risk for the next mailing. Page 5 of 5
DAT-B 2015 Direct Antiglobulin Test
EVALUATION DAT-B 2015 Direct Antiglobulin Test INSTITUTION: ATTENTION: CAP NUMBER: 7181660-01 Kit# 1 KIT INFORMATION: Kit ID: 28002258 10/12/2015 11/16/2015 Next Mailing Date: 2/22/2016 COPIED TO: LAP
VM-A 2011 Viral Markers
EVALUATION VM-A 2011 Viral Markers INSTITUTION: ATTENTION: CAP NUMBER: 7181660-01 Kit# 1 KIT INFORMATION: Kit ID: 23929821 1/3/2011 2/8/2011 Next Mailing Date: 9/2011 COPIED TO: LAP CAP LEGEND: Exception
PROFICIENCY TESTING. Clinical Laboratory Improvement Amendments (CLIA) DOs and DON Ts. Brochure # 8
Clinical Laboratory Improvement Amendments (CLIA) Brochure # 8 PROFICIENCY TESTING DOs and DON Ts NOTE: Congress passed the Clinical Laboratory Improvement Amendments (CLIA) in 1988 establishing quality
M E D I C A L L A B O R A T O R Y
M E D I C A L L A B O R A T O R Y E V A L U A T I O N PARTICIPANT SUMMARY 2 0 1 5 Immunology MLE-M2 Total Commitment to Education and Service Provided by ACP, Inc. Table of Contents Evaluation Criteria...
M E D I C A L L A B O R A T O R Y
M E D I C A L L A B O R A T O R Y E V A L U A T I O N PARTICIPANT SUMMARY 2 0 1 6 Immunology 2016 MLE-M3 Total Commitment to Education and Service Provided by ACP, Inc. Table of Contents Evaluation Criteria...
M E D I C A L L A B O R A T O R Y
M E D I C A L L A B O R A T O R Y E V A L U A T I O N PARTICIPANT SUMMARY 2 0 1 5 Immunology MLE-M1 Total Commitment to Education and Service Provided by ACP, Inc. Table of Contents Evaluation Criteria...
M E D I C A L L A B O R A T O R Y
M E D I C A L L A B O R A T O R Y E V A L U A T I O N PARTICIPANT SUMMARY 2 0 1 1 Total Commitment to Education and Service Provided by ACP, Inc. Immunology MLE M1 Table of Contents 2011 Evaluation Criteria...
M E D I C A L L A B O R A T O R Y
M E D I C A L L A B O R A T O R Y E V A L U A T I O N PARTICIPANT SUMMARY 2 0 1 7 Immunology 2017 MLE-M3 Total Commitment to Education and Service Provided by ACP, Inc. Table of Contents Evaluation Criteria...
Transfusion Medicine (Comprehensive, Limited) J, J1
www.cap.org Transfusion Medicine Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS). Transfusion Medicine (Comprehensive, Limited)
M E D I C A L L A B O R A T O R Y
M E D I C A L L A B O R A T O R Y E V A L U A T I O N PARTICIPANT SUMMARY 2 0 1 4 Immunology MLE-M1 Total Commitment to Education and Service Provided by ACP, Inc. Table of Contents Evaluation Criteria...
M E D I C A L L A B O R A T O R Y
M E D I C A L L A B O R A T O R Y E V A L U A T I O N PARTICIPANT SUMMARY 2 0 1 3 Total Commitment to Education and Service Provided by ACP, Inc. Immunology MLE-M2 Table of Contents Evaluation Criteria...
M E D I C A L L A B O R A T O R Y
M E D I C A L L A B O R A T O R Y E V A L U A T I O N PARTICIPANT SUMMARY 2 0 1 7 Immunology 2017 MLE-M1 Total Commitment to Education and Service Provided by ACP, Inc. Table of Contents Evaluation Criteria...
CLIA APPROVED PROFICIENCY TESTING PROGRAMS ACCUTEST, INC. P.O. Box 999 Westford, Massachusetts (800)
ACCUTEST, INC. P.O. Box 999 Westford, Massachusetts 01886 (800) 665-2575 MICROBIOLOGY Bacteriology Aerobic Culture and Identification Antibiotic Susceptibility Testing Direct Antigen Detection Gram Stain
Proficiency Testing LABFACTS Requirements for good laboratory practice and COLA Laboratory Accreditation programs are underlined.
Proficiency Testing LABFACTS 8 INTRODUCTION Proficiency testing (PT) is an important aspect of an overall quality assurance program. PT serves as an external check to verify the accuracy of a 's results
REFERENCE LABORATORY. Regular Hours - Monday through Friday 8:00 AM to 4:00 PM. On-Call Staff - Evenings, Nights, Weekend and Holidays.
I. REFERENCE LABORATORY HOURS OF OPERATION: Regular Hours - Monday through Friday 8:00 AM to 4:00 PM. On-Call Staff - Evenings, Nights, Weekend and Holidays. All Reference Lab procedures are subject to
Primary Sample Manual Infectious Serology Issue No Effective Date: 20/09/17 Page 1 of 15 EUROFINS BIOMNIS
Issue No. 2.02 Effective Date: 20/09/17 Page 1 of 15 Written / Revised By: Dr. Mike Louw, Medical Director Date: Reviewed By: Date: Dr. Sinead Kelly, Infectious Serology Consultant Authorised By: Jean-Sébastien
Reflex Test Protocols
UCH Clinical Laboratory Reflex Test Protocols Blood Bank Prepare RBCs for Transfusion (aka Crossmatch) N/A No Antibody Screen ordered Antibody Screen Direct Antiglobulin Test (DAT) Polyspecific DAT Positive
INSTRUCTIONS FOR BLOOD BANK INSPECTION CHECKLIST AND REPORT CMS-282
Note to Surveyors: INSTRUCTIONS FOR BLOOD BANK INSPECTION CHECKLIST AND REPORT CMS-282 This form consists of portions of the FDA-2609. These portions are the only parts of the FDA-2609 that have been approved
Reflex Test Protocols
Blood Bank Prepare RBCs for Transfusion (aka Crossmatch) N/A No Antibody Screen ordered Antibody Screen Direct Antiglobulin Test (DAT) Polyspecific DAT Positive polyspecific DAT IgG DAT, C3 DAT Fetal Cell
Learning Objectives. New HIV Testing Algorithm from CDC. Overview of HIV infection and disease 3/15/2016
New HIV Testing Algorithm from CDC ASCLS-Michigan March 31, 2016 Dr. Kathleen Hoag Learning Objectives Following attendance and review of material provided, attendees will be able to: 1. Describe the new
Controls & Calibrators. Disease Quality Controls
Controls & Calibrators Infectious Disease Quality Controls Infectious Disease Quality Controls A broad selection of controls designed to monitor assay precision of hepatitis, retrovirus, sexually transmitted
Transfusion Reactions. Directed by M-azad March 2012
Transfusion Reactions Directed by M-azad March 2012 Transfusion Reactions are Adverse reactions associated with the transfusion of blood and its components Transfusion reactions Non-threatening to fatal
READ HIGHLIGHTED CHANGES
BIO-FLASH anti-hbs 3000-8581 100 tests The BIO-FLASH anti-hbs is a fully automated chemiluminescent simultaneous immunoassay for quantitative measurement of antibodies to Hepatitis B surface antigen (anti-hbs)
q,a;e Fc ) ORIGINAL EVALUATION. FH9-B 2017 Hematology Auto Differentials, FH9
etiee INSTITUTION: ATTENTION: CAP NUMBER: KIT INFORMATION: COPIED TO: LKF Laboratorium fur Klinische Forschung GmbH Schwentinental GE 24223 Volker El-Samalouti PhD 7234136-01 Kit# 1 Kit ID: Kit Mailed:
HIV Viral Load Quality Assessment Program Summary for Panel HIVVL 2017Oct27
1 The National Laboratory for HIV Reference Services is Accredited to ISO 15189 and ISO 17043 National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology
Blood transfusion. Dr. J. Potgieter Dept. of Haematology NHLS - TAD
Blood transfusion Dr. J. Potgieter Dept. of Haematology NHLS - TAD General Blood is collected from volunteer donors >90% is separated into individual components and plasma Donors should be: healthy, have
Immunohematology. IH-QC Modular System. Select. Combine. Control.
Immunohematology IH-QC Modular System Select. Combine. Control. IH-QC Modular System Select. Combine. Control. Transfusion guidelines recommend regular checking of test materials, test methods, local working
The testing of Donated Blood and Components at NHSBT
The testing of Donated Blood and Components at NHSBT NHSBT is responsible for collecting all donated blood and platelets in England, then processing into components before issuing to client hospitals.
Disclosures. Relevant Financial Relationship(s): Nothing to Disclose. Off Label Usage: Nothing to Disclose 9/19/2017. Proficiency Testing
September 11, 2017 Teri Ross, Quality Specialist II Doreen Ryan, MA, MT; Quality Operations Supervisor Deborah J. Wells, MPA, MT(ASCP)SH, Quality Management Coordinator Disclosures Relevant Financial Relationship(s):
AccuVert HBV Seroconversion Panel PHM941(M) ( )
PACKAGE INSERT PHM941(M) (0605-0061) INTENDED USE PHM941(M) (0605-0061) is a group of serial bleeds from an individual plasma donor during HBV seroconversion. This panel is intended for use by diagnostics
Uniplas Das Einheitsplasma für jedermann
Uniplas Das Einheitsplasma für jedermann Petra Jilma, MD Medical University of Vienna, Vienna, Austria ÖGBT, Juni 2013 UNIPLAS Universal plasma is a novel, blood group independent human pooled plasma and
SOURCES OF ERROR IN SEROLOGIC AND IMMUNOLOGIC LAB. Lecture by: Dr. Forouzan Karimi; PharmD, PhD
SOURCES OF ERROR IN SEROLOGIC AND IMMUNOLOGIC LAB Lecture by: Dr. Forouzan Karimi; PharmD, PhD fkarimi@sbmu.ac.ir C-REACTIVE PROTEIN RAPID LATEX AGGLUTINATION TEST SOURCES OF ERROR False-positive results
TEST REQUEST INFORMATION- VIROLOGY
Chlamydia/ Gonorrhea Nucleic Acid Amplification VC75 Qualitative Nucleic Acid Amplification SPECIMEN: Genital swab or first catch urine CONTAINER:GEN-PROBE APTIMA 2 Combo swab transport tube or urine transport
Frequency of occult hepatitis B in HBsAg seronegative blood donors in a tertiary care hospital in kerala,south India.
Frequency of occult hepatitis B in HBsAg seronegative blood donors in a tertiary care hospital in kerala,south India. Cinzia Keechilot, Veena Shenoy 1,V Anil kumar 2,Lalita Biswas 3. MBBS student * Transfusion
HIV Viral Load Quality Assessment Program Summary for Panel HIVVL 2018Oct26
1 National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory Public Health Agency of Canada HIV Viral Load Quality Assessment Program Summary
NLBCP-017 INDIRECT ANTIGLOBULIN CROSSMATCH TUBE METHOD. Issuing Authority
Government of Newfoundland and Labrador Department of Health and Community Services Provincial Blood Coordinating Program INDIRECT ANTIGLOBULIN CROSSMATCH TUBE METHOD Office of Administrative Responsibility
MP Biomedicals Asia Pacific Pte. Ltd. (formerly Genelabs Diagnostics Pte. Ltd.)
Revision: 12 May 2005 1 WESTERN BLOT / IMMUNOBLOT HIV-1 BLOT Version 1.3* 11010-018 HIV-1 viral lysate Western Blot assay for the 11010-036 detection of antibodies to HIV-1 with serum 11010-108 108 strips
PROPOSED USE This method is used for determining plasma reagins in human sera.
Agglutination Assay -glass slide For "in vitro" use only Store at 2-8 C INTRODUCRION Syphilis is a sexually transmitted disease caused by Treponema pallidum. The main tests used to diagnose syphilis are:
Susanne Norris Zanto, MPH, MLS (ASCP) CM, SM Montana Public Health Laboratory
Susanne Norris Zanto, MPH, MLS (ASCP) CM, SM Montana Public Health Laboratory Describe the challenges in syphilis diagnostics Present two testing algorithms Non-treponemal test as initial screen Treponemal
2019 HIV Diagnostics Conference March 27, 2019
2019 HIV Diagnostics Conference March 27, 2019 Performance of the Syphilis Reverse Algorithm Using the Abbott Architect Syphilis TP (ASTP) and its Role in a Blended Diagnostic Application in Florida s
The Alphabet Soup of Viral Hepatitis Testing
The Alphabet Soup of Viral Hepatitis Testing August 18, 2011 Patricia Slev, PhD, DABCC Medical Director, Serologic Hepatitis and Retrovirus Laboratory, ARUP Laboratories Assistant Professor of Pathology,
Diagnostic Methods of HBV infection. Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO)
Diagnostic Methods of HBV infection Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO) Hepatitis B-laboratory diagnosis Detection of HBV infection involves
SOLE-SOURCE DETERMINATION
SOLE-SOURCE DETERMINATION The Purchasing Division has been requested to approve a sole source purchase for the commodity or service described below. Pursuant to West Virginia Code 5A-3-10c, the Purchasing
TRANSFUSION REACTIONS
14 TRANSFUSION REACTIONS 14.1 INTRODUCTION Transfusion of blood and blood products are reported to cause reactions during or after procedure specially in patients who receive multiple transfusions. These
PRODUCT CATALOGUE YOUR GLOBAL PARTNER IN DIAGNOSTICS
PRODUCT CATALOGUE YOUR GLOBAL PARTNER IN DIAGNOSTICS WELCOME Omega Diagnostics Ltd is a wholly owned subsidiary of Omega Diagnostics Group PLC. Formed in 1987, Omega is one of the UK s leading manufacturers
Trends in molecular diagnostics
Trends in molecular diagnostics Detection of target genes of interest Quantification Infectious diseases HIV Hepatitis C & B TB / MAC Cytomegalovirus Herpes simplex Varicella zoster CT/GC HPV Profiling
Duration: 12 months May to April
SPECIALIST CERTIFICATE IN TRANSFUSION SCIENCE PRACTICE PROGRAMME OF STUDY OVERVIEW Example only Duration: 12 months May to April This document serves as a general programme overview only. To ensure you
AccuVert HIV-1 Seroconversion Panel PRB955 ( ) / Batch #
Signal to cutoff (s/co) Copies per ml (c/ml) OVERVIEW AccuVert is a 5-member validation panel of undiluted, naturally occurring plasma samples (1 vial per member, 1.0 ml per vial). Panel members represent
AIHA The Laboratory Perspective on Testing. Tom Bullock Joint UK NEQAS (BTLP) & BBTS BBT SIG Annual Meeting 20 th November 2018
AIHA The Laboratory Perspective on Testing Tom Bullock Joint UK NEQAS (BTLP) & BBTS BBT SIG Annual Meeting 20 th November 2018 Auto Immune Haemolytic Anaemia (AIHA) BSH guideline (Hill et al. 2017): AIHA
Guidance for Industry
Guidance for Industry Revised Recommendations for Donor and Product Management Based on Screening Tests for Syphilis DRAFT GUIDANCE This document is being distributed for comment purposes only. Submit
DS-EIA-ANTI-HIV-UNIF (Ab) I DS-EIA-ANTI-HIV-UNIF (Ab) I DS-EIA-ANTI-HIV-UNIF (Ab) I
* Sensitivity HIV DS-EIA-ANTI-HIV-UNIF (Ab) I-153 96 115 24 DS-EIA-ANTI-HIV-UNIF (Ab) I-150 192 115 24 DS-EIA-ANTI-HIV-UNIF (Ab) I-155 480 115 24 DS-EIA-HIV-AG-SCREEN I-1452 96 115 12 0.025 IU/ml DS-EIA-HIV-AGAB-SCREEN
2014/LSIF/PD/025 Malaysia s Approach to Testing Strategies
2014/LSIF/PD/025 Malaysia s Approach to Testing Strategies Submitted by: Malaysia Policy Dialogue and Workshop on Attaining a Safe and Sustainable Blood Supply Chain Manila, Philippines 30 September 1
Bulk Assay Supply Catalog
Bulk Assay Supply Catalog Living Immunoassay Excellence Biokit is a privately owned biotechnological company that is part of Werfen. It was founded in 1973 and is aimed at the research, development, manufacture
FINAL REPORT HBV Serology External Quality Assessment Scheme
FINAL REPORT HBV Serology External Quality Assessment Scheme Programme codes: HBVC4310, HBVC435 Panel ID: 2008/Mar/11 HBV Serology EQAS Panel ID 2008/Mar/11 Page 1 of 9 The NRL is a: NATA-accredited proficiency
AccuSet HBV Worldwide Performance Panel
PACKAGE INSERT 0805-033 INTENDED USE The is intended for use by diagnostic manufacturers, researchers, and clinical laboratories to develop, evaluate, or troubleshoot HBV test methods. Characterized samples
Evolution of HIV Diagnostics. Goals for the 2010 Conference. Bernard M. Branson, M.D. CDC Division of HIV/AIDS Prevention
Evolution of HIV Diagnostics and Goals for the 2010 Conference Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics CDC Division of HIV/AIDS Prevention Evolution or other influences like
ORIGINAL EVALUATION. FH9-C 2017 Hematology Auto Differentials, FH9
ft Cit e * 4> ee e e e *111» * * PAT H 0 LO GI STS INSTITUTION: ATTENTION: CAP NUMBER: KIT INFORMATION: COPIED TO: LKF Laboratorium fur Klinische Forschung GmbH Schwentinental GE 24223 Volker El-Samalouti
PILOT STUDY OF ANTIGEN MATCHING FOR AUTOIMMUNE HEMOLYTIC ANEMIA
PILOT STUDY OF ANTIGEN MATCHING FOR AUTOIMMUNE HEMOLYTIC ANEMIA Sharon Rice & Fred Plapp Saint Luke s Hospital Kansas City, MO CENTRALIZED TRANSFUSION SERVICE Antibody identification Antibody titer Antigen
MEDICAL DEVICE GUIDANCE DOCUMENT
MDA/GD/IVD-1 July 2013 First Edition MEDICAL DEVICE GUIDANCE DOCUMENT IN-VITRO DIAGNOSTIC (IVD) MEDICAL DEVICE CLASSIFICATION SYSTEM Medical Device Authority MINISTRY OF HEALTH MALAYSIA Contents Page Preface...
Documentation, Codebook, and Frequencies
2 Documentation, Codebook, and Frequencies Laboratory Component: Hepatitis B: core antibody, surface antibody and surface antigen; Hepatitis C: confirmed antibody; Hepatitis D antibody Survey Years: 2003
Reporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey
Reporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey This questionnaire consists of three sections: A. Collection and
Brrrr, It s Cold In Here
Brrrr, It s Cold In Here Kate Grogan, MD Transfusion Medicine Fellow Physician, BloodworksNW 4/24/15 Patient 20 year old female Viral illness Presents one week later with severe hemolysis Hgb 5.6 Increased
Multichem Infectious Disease QC
Infectious Disease QC Contents Introduction....3 Quality Control in the Laboratory...4 Infectious Disease (ID) QC....5 Ready-to-use Concept....6 NRL...7 QConnect...8 IAMQC in Collaboration with QConnect....
Tel: Tel: Web: CODE DESCRIPTION UNITS
New Instruments MICROPLATE ANALYZERS DESCRIPTION UNITS MDIMOD2 Modulus2 2-4 Microplate Analyzer 1 Refurbished Instruments MICROPLATE ANALYZERS DESCRIPTION UNITS MDINXGMI Refurbished Nexgen 4-Microplate
Official Journal of the European Communities COMMISSION
16.5.2002 EN Official Journal of the European Communities L 131/17 COMMISSION COMMISSION DECISION of 7 May 2002 on common technical specifications for in vitro-diagnostic medical devices (notified under
AccuSet Autoimmune Performance Panel
PACKAGE INSERT 0840-0001 INTENDED USE The 0840-0001 is intended for use by diagnostic manufacturers, researchers, and clinical laboratories to develop, evaluate, or troubleshoot autoimmune related test
Answering your daily challenges. in the ELISA technology I N FECTI OUS DISEASES. bioelisa
Answering your daily challenges in the ELISA technology I N FECTI OUS DISEASES bioelisa RETROVIRUS HIV is the cause of the most important global pandemic. Due to the lack of vaccination, early diagnosis
ELISA kits for infections (HIV; Hepatitis A, B, C, D, E; Syphilis, ToRCH and others), hormone pathologies and tumor markers.
DSI S.r.l. DSI S.r.l. is one of the European leaders in the field of immunodiagnostic tests manufacturing. We are a research-focused company with the long-term microbiological scientific traditions. Our
2014 Continuing Compliance Master Series Best Practices in Alternative Assessment of Performance
2014 Continuing Compliance Master Series Best Practices in Alternative Assessment of Performance Brad S. Karon, MD, PhD, FCAP November 19, 2014 www.cap.org Today s Presenter Brad S. Karon, MD, PhD, FCAP
Parvovirus B19 Mixed Titer Performance Panel PVP201
A SERACARE PANEL PRODUCT INTENDED USE The is a panel of naturally occurring plasma specimens. This panel is intended for use by diagnostic manufacturers and clinical laboratories to evaluate their Parvovirus
Principles of In Vitro Diagnostic (IVD) Medical Devices Classification
Technical Reference: TR-006 Date of Issue: 1 Dec. 2009 Principles of In Vitro Diagnostic (IVD) Medical Devices Classification Technical Reference: TR-006 Department of Health The G overnment of the Hong
Structure and duties of Blood service
NATIONAL CENTER FOR TRANSFUSION MEDICINE Prevalence of infectious diseases among Mongolian blood donors Namjil Erdenebayar General director of The National Center for Transfusion Medicine, Mongolia NCTM,
Lab Guide Blood Bank Section Lab Guide
Lab Guide - 2018 Blood Bank Section Lab Guide 1.1. Laboratory Tests Provided by Blood Banks: ABO/Rh Typing Neonates Less than 4months =1ml Children 2Years and above including adults =4ml Routine: within
G-B 2016 Kit Instructions CAP 2016
G-B 2016 Kit Instructions CAP 2016 Syphilis Serology Survey Table of Contents Kit Contents Kit Contents... 1 Important: Before You Begin... 1 Detailed Testing Instructions... 1 Reporting Your Results...
Blood Screening Assays. CTS lab locations where assays are performed are indicated by alpha codes D, P, and T.
Blood Screening Assays CTS lab locations where assays are performed are indicated by alpha codes D, P, and T. D= performed in Dallas lab FEI: 3002580251 P= performed in Phoenix lab FEI: 3000204058 T= performed
See external label 2 C-8 C 96 tests Chemiluminescence. CMV IgM. Cat # Diluted samples, controls & calibrator 100 µl 30 minutes
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
DIAGNOSTIC AUTOMATION, INC.
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
Taken From VBA s Adjudication Procedure Manual Section on Hepatitis
Taken From VBA s Adjudication Procedure Manual Section on Hepatitis M21-1, Part III, Subpart iv, 4.I.2 Updated January 11, 2017 2. Hepatitis and Other Liver Disabilities Introduction Change Date January
Study of ChLIA and ELISA for TTI Markers in Blood Donors
Study of ChLIA and ELISA for TTI Markers in Blood Donors Presenting Author - Miss Kiran Kachhadiya (Co-authors: Dr. Vachhani N., Mrs. Bhatt J, Dr. Jani F., Dr. Nandani S.) Life Blood Centre (Formerly known
2. Liver blood tests and what they mean p2 Acute and chronic liver screen
1 Scope For use within hepatology Contents 2. Liver blood tests and what they mean p2 Acute and chronic liver screen p2 Common reasons for referral 3. Raised ALT +/- GGT p3 4. Non alcoholic fatty liver
True Status A B. HTLV I Positive. Indeterminate. HTLV I/II Negative HV15 HV16 HV18 HV21 HV22 HV44 HV55. Selected Legend: Flagged: Unresolved
National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory HTLV Serology Quality Assessment Program Summary for Panel HTLVSER 206Apr2 Panel
Proficiency Testing Evaluation
Facility/Contact Phone: (573)265-8840 PCRMC Medical Group - Forest C Fax: (573)265-8884 1000 N Jefferson St Email (primary): odean@pcrmc.com; Email (secondary): (Please add pt@aafp.org to your electronic
Significance of Antibodies and appropriate selection of red cells for transfusion Chris Elliott Haematology Service manager
Significance of Antibodies and appropriate selection of red cells for transfusion Chris Elliott Haematology Service manager James Cook University Hospital Friarage Hospital Over the next 30 minutes Bit
HIV-1 AccuVert Seroconversion Panel (PRB966) / Batch #
s/co c/ml DATA SHEET OVERVIEW 0600-0248 (PRB966) is a 10-member panel of undiluted, naturally occurring plasma samples. Panel members represent serial bleeds collected from a single patient over the course
Non-reproductive tissues and cells Recommending authority/ association
Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding More stringent - recommended Not legy binding and not recommended Tested pathogen Donor test/ technique
This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents
2002D0364 EN 01.07.2012 002.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B COMMISSION DECISION of 7 May 2002 on common technical
BIO-FLASH. BIOKIT, S.A. - Can Malé s/n Lliçà d Amunt - Barcelona - SPAIN
READ HIGHLIGHTED CHANGES BIO-FLASH anti-hbc 3000-8578 100 tests The BIO-FLASH anti-hbc is a fully automated chemiluminescent two-step immunoassay for qualitative measurement of total antibodies to hepatitis
BLOOD SAFETY STATUS IN INDONESIA. Yuyun Soedarmono Chairman of the Indonesian Association of Transfusion Medicine
BLOOD SAFETY STATUS IN INDONESIA Yuyun Soedarmono Chairman of the Indonesian Association of Transfusion Medicine OUTLINE Background Blood services in Indonesia Regulation related to blood safety in Indonesia
Results of the College of American Pathologists (CAP) Proficiency Program for CMV, EBV, and BKV Viral Load Testing
2009 College of American Pathologists. The College does not permit reproduction of any substantial portion of the material in this Report without its written authorization. The College hereby authorizes
NEWS BK NEWS # 378 /MKT DATE : TITLE. Dear colleagues,
1 NEWS BK NEWS # 378 /MKT DATE : 16022016 TITLE : New Bioelisa reagents Brochures Dear colleagues, We are pleased to present the new Bioelisa reagents Brochures, which are a very useful marketing and selling
Immunohaematology: a branch of immunology that deals with the immunologic properties of blood.
1 Immunohaematology: a branch of immunology that deals with the immunologic properties of blood. The red blood cells have on their surface hundreds of antigens and according to the antigen on their surface
Quality Control Solutions
Quality Control Solutions 1 CONTENT QCONNECT 3 ABOUT DIAMEX 6 ABOUT NRL 7 ABOUT EXACT DIAGNOSTICS 7 PRODUCTS 8 SEROLOGY MULTIMARKER RANGE 10 SEROLOGY SINGLE ANALYTE RANGE 16 NAT CONTROL RANGE 19 EXACT
2. Liver blood tests and what they mean p2 Acute and chronic liver screen
Hepatology referral pathways for GP 1 Scope For use within hepatology Contents 2. Liver blood tests and what they mean p2 Acute and chronic liver screen p2 Common reasons for hepatology referral 3. Raised
8/28/2018. Disclosures. Objectives. None. Automation to PreciseType and Everything in Between
Automation to PreciseType and Everything in Between Jessie Singer MT(ASCP) Transfusion Medicine Children s Hospital Los Angeles None Disclosures Objectives Describe the application of molecular testing
Automation to PreciseType and Everything in Between. Jessie Singer MT(ASCP) Transfusion Medicine Children s Hospital Los Angeles
Automation to PreciseType and Everything in Between Jessie Singer MT(ASCP) Transfusion Medicine Children s Hospital Los Angeles None Disclosures Objectives Describe the application of molecular testing
Product List Autobio Diagnostics Autobio. autobio diagnostics an autobio group company
Product List Autobio Diagnostics 2009-2010 Autobio.. autobio diagnostics an autobio group company www.autobio-diagnostics.com Autobio Diagnostics Co., Ltd. was established in 1998 and has become one of
Turbidos. Design Verification. Contents
Design Verification Turbidos Contents 1 adjustment... 2 2 Target value determination... 2 3 Stability... 2 3.1 Accelerated stress data... 2 3.2 Open vial stability... 3 3.3 Real Time Stability... 4 4 Result
Test Name Results Units Bio. Ref. Interval
LL - LL-ROHINI (NATIONAL REFERENCE 135091650 Age 49 Years Gender Male 29/8/2017 120000AM 29/8/2017 100248AM 29/8/2017 105306AM Ref By Final HEATITIS, VIRAL, COMREHENSIVE ANEL HEATITIS A ANTIBODY (ANTI
Innovation in Diagnostics. ToRCH. A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES
Innovation in Diagnostics ToRCH A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES EN TOXOPLASMOSIS Toxoplasmosis is a parasitic disease caused by with the obligate intracellular
WHO Prequalification of In Vitro Diagnostics Programme
WHO Prequalification of In Vitro Diagnostics Programme International HIV/Viral Hepatitis Co-Infection Satellite Meeting 19 July 2014, Melbourne Anita Sands Prequalification Diagnostics Team Department